Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 12/20 | 0.57 |
| ▸ | DPP9 | Q86TI2 | 9/20 | 0.57 |
| ▸ | DPP8 | Q6V1X1 | 9/20 | 0.57 |
| ▸ | DPP4 | P27487 | 6/20 | 0.57 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.53 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | RRM1 | P23921 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.37 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7613327 | 0.95 | DPP7 (0.58) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL10520841 | 0.92 | DPP7 (0.62) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL8721584 | 0.92 | DPP7 (0.58) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL2182733 | 0.86 | DPP7 (0.51) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL9797628 | 0.86 | DPP7 (0.50) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL8991404 | 0.86 | DPP7 (0.50) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL8495681 | 0.84 | DPP7 (0.56) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL7751944 | 0.83 | DPP7 (0.50) | DPP7DPP9DPP8DPP4GNAI3 | |
| SCHEMBL7751947 | 0.83 | DPP7 (0.50) | DPP7DPP9DPP8DPP4GNAI3 | |
| SCHEMBL2193195 | 0.81 | NPY4R (0.48) | DPP7DPP9DPP8DPP4SLC15A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166063-A1 | POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES | NEKTAR THERAPEUTICS (US) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166063-A1 | POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES | NGLY1, CD44, IAPP | DPP7 450/4885DPP9 996/4885DPP8 644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.